Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate

作者: F Javadi , P Rahimi , MH Modaressi , M Shafiee Ardestani , A Bolhassani

DOI: 10.18869/ACADPUB.VACRES.2.5.97

关键词: Combinatorial chemistryDendrimerNS3ConjugateRecombinant DNAChemistryCharacterization (materials science)

摘要:

参考文章(31)
Darius Moradpour, François Penin, Hepatitis C Virus Proteins: From Structure to Function Current Topics in Microbiology and Immunology. ,vol. 369, pp. 113- 142 ,(2013) , 10.1007/978-3-642-27340-7_5
Tobias Jung, Walter Kamm, Armin Breitenbach, Klaus‐Dieter Hungerer, Erika Hundt, Thomas Kissel, Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharmaceutical Research. ,vol. 18, pp. 352- 360 ,(2001) , 10.1023/A:1011063232257
Mohammad Shafiee Alavidjeh, Ismaeil Haririan, Mohammad Reza Khorramizadeh, Zohre Zarei Ghane, Mehdi Shafiee Ardestani, Hassan Namazi, Anionic linear-globular dendrimers: biocompatible hybrid materials with potential uses in nanomedicine Journal of Materials Science: Materials in Medicine. ,vol. 21, pp. 1121- 1133 ,(2010) , 10.1007/S10856-009-3978-8
Craig A Belon, David N Frick, Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C. Future Virology. ,vol. 4, pp. 277- 293 ,(2009) , 10.2217/FVL.09.7
Matti Sällberg, Malin Weiland, Lars Frelin, Therapeutic vaccines: challenges of chronic viral infections Drug Discovery Today: Therapeutic Strategies. ,vol. 4, pp. 253- 266 ,(2007) , 10.1016/J.DDSTR.2008.02.004
Erik B Lindblad, Aluminium adjuvants—in retrospect and prospect Vaccine. ,vol. 22, pp. 3658- 3668 ,(2004) , 10.1016/J.VACCINE.2004.03.032
Saki Takei, Chika Omoto, Koichi Kitagawa, Naoya Morishita, Takane Katayama, Katsumi Shigemura, Masato Fujisawa, Masato Kawabata, Hak Hotta, Toshiro Shirakawa, Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine. ,vol. 32, pp. 3066- 3074 ,(2014) , 10.1016/J.VACCINE.2014.03.022
Jana Schlütter, Therapeutics: New drugs hit the target Nature. ,vol. 474, ,(2011) , 10.1038/474S5A